Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ICE vs GSK✓SelectedUSD · GSKICE vs GSK performance historyLatest closeAs of-0.54%11/19
Stock and ETF performance explorer

ICE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+251.9%
GSK return
+97.7%
Excess return
+154.2%
Maximum drawdown
-34.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.5%-1.6%+1.0%-0.1%
7D-3.9%-4.7%+0.8%-2.5%
30D+7.8%-4.7%+12.5%+9.3%
3M+9.0%-8.8%+17.8%+11.9%
6M+11.7%-4.6%+16.3%+12.8%
YTD+6.6%+1.0%+5.6%+5.1%
1Y+12.7%+6.9%+5.8%+9.1%
3Y+59.2%+52.5%+6.7%+32.0%
5Y+36.9%+40.3%-3.4%+15.3%
All+251.9%+97.7%+154.2%+167.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling